WithdrawnNot Applicable

Male Fertility and Sperm Cryopreservation

Stopped: PI is no longer at this University.

United States0Started 2015-05

Plain-language summary

PURPOSE: Primary objective: To assess the feasibility and outcomes of male fertility preservation by sperm freezing prior to starting treatment requiring alkylating agents and/or total body irradiation. Secondary objective: To assess pre- and post-treatment sperm production and hormonal status by measurement of serum anti-mullerian hormone (AMH), inhibin-B, follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone, and androstendione.

Who can participate

Age range13 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * male, aged 13 years or older, * diagnosed with cancer, but not yet undergoing therapy * willing to participate in this clinical trial * signed Informed consent document Exclusion Criteria: * under 13 years old * have already begun Chemo or radiotherapy

What they're measuring

Semen and lab parameters pre-cancer treatment.

Timeframe: On Day 1/Visit 1 (1 hour and 30 minutes)

Semen and lab parameters post-cancer treatment.

Timeframe: Day 2/ Visit 2; 4 months after the completion of chemotherapy or radiotherapy

Trial details

NCT IDNCT02431000

SponsorUniversity of Tennessee

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-06-30

View on ClinicalTrials.gov More Fertility trials